STROBER, B.; AUGUSTIN, M.; TADA, Y.; GARG, A.; JULLIEN, D.; GOTTLIEB, A.; GUDJONSSON, J.; HU, N.; HOFMANN, P.; THOMA, C.; MARZANO, A. Effect of High-Dose Subcutaneous Spesolimab on Skin Manifestations: Results from the Pivotal Effisayil 2 Trial of Flare Prevention in Generalized Pustular Psoriasis. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 8, n. 2, p. s371, 2024. DOI: 10.25251/skin.8.supp.371. Disponível em: https://jofskin.org/index.php/skin/article/view/2716. Acesso em: 3 jul. 2024.